Septerna (SEPN) CMO Rajiv Patni Receives 275,000-Share Award

What Happened

• Rajiv Patni, Chief Medical Officer of Septerna, was granted a derivative award for 275,000 shares on 2026-09-08. The grant shows an acquisition price of $0.00 (i.e., an awarded option/RSU-type instrument) and a reported total value of $0 on the Form 4 (derivative transaction code A).
• This was a compensation award (not an open-market purchase or sale), so it does not reflect an immediate cash outlay or share sale.

Key Details

• Transaction date: 2026-09-08; Form 4 filed: 2026-09-10 (timely).
• Reported transaction: 275,000 shares acquired at $0.00 (derivative award, code A).
• Shares owned after transaction: not specified in the filing.
• Footnote: 25% of the shares underlying this option vest on August 24, 2027; the remaining 75% vest in 36 substantially equal monthly installments thereafter, subject to continuous service.
• No indication of a 10b5-1 plan, tax-withholding sale, or late filing in this filing.

Context

• This is a typical equity compensation grant for an executive; as a derivative award, the shares are subject to vesting and are not immediately marketable until vested (or exercised, if options).
• Such grants are common for retention and incentive purposes and should not be interpreted alone as a bullish or bearish signal about the stock.